PROPRANOLOL IMPAIRS RECONSOLIDATION OF CONDITIONED FEAR
IN HUMANS |
M.M.Miller1,4*; M.Altemus2;
J.Debiec3; J.E.LeDoux3; E.A.Phelps4 |
1. Lab. of Neuroendocrinology, Rockefeller Univ, New York, NY,
USA |
2. Dept of Psychiatry, Weill Med. Col., Cornell Univ, New York,
NY, USA |
3. Ctr for Neural Sci, 4. Dept of Psychology, New York Univ,
New York, NY, USA |
|
Recent studies in rats suggest that previously stable, long-term
memories of fear conditioning return to a labile state after re-exposure
to the conditioned stimulus. In the present study, we examined whether reconsolidation
occurs for a conditioned fear memory in humans, and whether it might be
blocked by the beta-adrenergic receptor antagonist propranolol. The experiment
consisted of 3 phases (training, re-exposure, and extinction) performed
on 3 consecutive days. On Day 1, all subjects viewed colored squares, which
served as the CS+ and CS-, on a computer screen. The CS+ was intermittently
paired with a shock to the wrist on Day 1, and Galvanic Skin Response (GSR)
was recorded as a measure of conditioning. On Day 2, two groups of subjects
were briefly re-exposed to the CS+ and CS-. Immediately after re-exposure,
subjects received either 40mg propranolol (oral dose) or placebo. A third
group of subjects received propranolol in a novel environment without exposure
to the stimuli. On Day 3, all subjects were exposed to the CS+ and CS- without
shock, and GSR was recorded. During the Day 3 extinction test, the placebo
group showed higher GSR to the CS+ than to the CS-. Similarly, the group
that received propranolol with no re-exposure showed higher GSR to the CS+
than CS-. However, the group that received propranolol immediately after
re-exposure did not show a differential response to CS+ vs. CS-. These results
suggest that propranolol impairs the reconsolidation of fear memory in humans.
Support Contributed By: MH58911, MH62104, M01RR0047
|
Program No. 208.2
Poster presentation:Sunday, Oct. 24, 9:00 AM - 10:00 PM
Location: NN17 |
 |
|
|